Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

AstraZeneca’s Lynparza gets EU nod as first-line ovarian cancer maintenance treatment

expresspharmaJune 21, 2019

Tag: AstraZeneca , EU , ovarian cancer

PharmaSources Customer Service